ABSTRACT
This report describes the five-year experience of the first 250 acceptors of NORPLANT implants in Assiut, Egypt. The five-year net continuation rate was 58.6 per 100 women. The five-year net cumulative pregnancy rate was 1.6 per 100 women. About three-fourths of those who continued use of this contraceptive through the fifth year reported having regular cycles. There was definite improvement in the bleeding pattern with time. The five-year net termination rate because of bleeding problems was 17.7 per 100 women. After 5 years of NORPLANT use there was a slight, statistically insignificant increase in weight, systolic and diastolic blood pressures. Of those who used contraceptives after the end of the five-year term of NORPLANT, about one-third opted to have reinsertion of the implants for a second term. About 96% of those who used NORPLANT through the fifth year reported that their experience with the contraceptive had been satisfactory.
PIP: This report describes the 5-year experience of the 1st 250 acceptors of Norplant implants in Assiut, Egypt. The 5 year net continuation rate was 58.6/100 women. The 5-year net cumulative pregnancy rate was 1.6/100 women. About 3/4 of those who continued use of this contraceptive through the 5th year reported having regular cycles. There was definite improvement in the bleeding pattern with time. The 5-year net termination rate because of bleeding problems was 17.7/100 women. After 5 years of Norplant use there was a slight, statistically insignificant increase in weight, systolic and diastolic blood pressures. Of those who used contraceptives after the end of the 5 year term of Norplant, about 1/3 opted to have reinsertion of the implants for a 2nd term. About 96% of those who used Norplant through the 5th year reported that their experience with the contraceptive had been satisfactory.
